Display options
Share it on

Front Mol Neurosci. 2021 Nov 01;14:743986. doi: 10.3389/fnmol.2021.743986. eCollection 2021.

Editorial: Tau Protein: Mechanisms From Health to Degeneration.

Frontiers in molecular neuroscience

Isabel Lastres-Becker

Affiliations

  1. Department of Biochemistry, School of Medicine, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
  2. Instituto de Investigación Sanitaria La Paz (IdiPaz), Instituto de Investigaciones Biomédicas "Alberto Sols" UAM-CSIC, Madrid, Spain.
  3. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
  4. School of Medicine, Instituto Teófilo Hernando, Universidad Autónoma de Madrid (UAM), Madrid, Spain.

PMID: 34790096 PMCID: PMC8591092 DOI: 10.3389/fnmol.2021.743986

[No abstract available.]

Keywords: TAU; TAU phosphorylation; TAU propagation; TAU treatment; tauopathies

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. FEBS Lett. 2018 Apr;592(7):1079-1095 - PubMed
  2. Am J Pathol. 2017 Jun;187(6):1222-1229 - PubMed
  3. Brain Res Mol Brain Res. 1996 Jun;38(2):200-8 - PubMed
  4. Lab Invest. 2019 Jul;99(7):1068-1077 - PubMed
  5. J Neurosci. 2011 Jul 6;31(27):9858-68 - PubMed
  6. Acta Neuropathol Commun. 2017 Dec 19;5(1):99 - PubMed
  7. Nature. 2020 Apr;580(7803):381-385 - PubMed
  8. Eur J Neurosci. 2005 Oct;22(8):1942-50 - PubMed
  9. Nat Commun. 2017 Aug 17;8(1):275 - PubMed
  10. J Biol Chem. 2008 Nov 14;283(46):32066-76 - PubMed
  11. Nat Commun. 2015 Dec 16;6:10216 - PubMed
  12. J Biol Chem. 2013 Jan 18;288(3):1856-70 - PubMed
  13. Front Neurol. 2018 Oct 02;9:809 - PubMed
  14. Biochemistry. 2006 Feb 21;45(7):2283-93 - PubMed
  15. Biomolecules. 2016 Jan 06;6(1):6 - PubMed

Publication Types